Liquid Biopsy clinical trials at UCSF
1 research study open to eligible people
Liquid biopsy is a way to detect cancer by examining blood. UCSF is conducting research on opening the blood-brain barrier to study brain tumors. The trial focuses on glioblastoma to evaluate new methods of using blood tests for tumor analysis.
Showing trials for
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects with GlioBlastoma Brain Tumors
open to eligible people ages 18-80
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
San Francisco, California and other locations
Last updated: